Net Income (TTM) Chart

View Net Income (TTM) for AMLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (TTM) Chart
Start Trial

Historical Net Income (TTM) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 -152.09M
March 31, 2026 -150.11M
December 31, 2025 -144.74M
September 30, 2025 -149.28M
June 30, 2025 -187.60M
March 31, 2025 -218.86M
December 31, 2024 -301.74M
September 30, 2024 -259.47M
June 30, 2024 -165.87M
March 31, 2024 -71.10M
December 31, 2023 49.27M
Date Value
September 30, 2023 1.836M
June 30, 2023 -72.81M
March 31, 2023 -148.95M
December 31, 2022 -198.38M
September 30, 2022 -184.02M
June 30, 2022 -153.40M
March 31, 2022 -121.26M
December 31, 2021 -87.93M
September 30, 2021 -68.18M
June 30, 2021 -45.04M

Net Income Definition

Represents net income for the period and date(s) requested in local currency by default.

Read full definition.

Net Income (TTM) Range, Past 5 Years

View Net Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (TTM) Benchmarks

View Net Income (TTM) Benchmarks
Start Trial
Pfizer Inc. 4.373B
Eli Lilly & Co. 26.71B
Merck & Co., Inc. 3.169B
EyePoint, Inc. -306.64M
Bristol Myers Squibb Co. 9.275B